Internal Medicine · Burlingame, CA
NPI
1649228917
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1860 El Camino Real, Suite 301
Burlingame, CA, 94010
Phone (650) 552-8100
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
2,194 services
Medicare patients, 2024
358
Average age 75
Drug cost, 2024
$1.5M
8,574 prescriptions
Company payments, 2025
$2,753
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel J Glatt was code 99214 (office e&m - established), 525 times for 240 patients. In total Daniel J Glatt billed 2,194 services in 33 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 525 | 240 | $105.01 | $55K |
| 80305 Drug Tests | Office | 494 | 148 | $12.33 | $6,090 |
| 99213 Office E&M - Established | Office | 430 | 227 | $74.49 | $32K |
| 99497 Care Management/Coordination | Office | 170 | 165 | $93.02 | $16K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 156 | 156 | $157.18 | $25K |
| G0008 Administration of influenza virus vaccine | Office | 83 | 82 | $38.68 | $3,210 |
| 90653 Vaccine Product | Office | 68 | 68 | $81.82 | $5,564 |
| 99215 Office E&M - Established | Office | 47 | 39 | $154.16 | $7,246 |
| 99204 Office E&M - New | Office | 39 | 39 | $113.50 | $4,427 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 34 | 26 | $47.34 | $1,610 |
| G0009 Administration of pneumococcal vaccine | Office | 17 | 17 | $38.68 | $658 |
| 90677 Vaccine Product | Office | 14 | 14 | $287.49 | $4,025 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $14.94 | $209 |
By year: 2022 $177K for 2,348 services; 2023 $213K for 2,730 services; 2024 $168K for 2,194 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 494 | 148 | $12.33 | $6,090 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel J Glatt prescribed most often to Medicare patients was Atorvastatin Calcium, with 419 prescriptions and refills. In total Daniel J Glatt wrote 8,574 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 419 | 1,150 | 148 | $5,188 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 373 | 373 | 47 | $9,743 |
| Oxycodone Hcl Generic | 362 | 362 | 43 | $15K |
| Gabapentin Generic | 285 | 541 | 84 | $7,204 |
| Morphine Sulfate Er Morphine Sulfate | 229 | 229 | 29 | $8,545 |
| Levothyroxine Sodium Generic | 183 | 473 | 69 | $2,507 |
| Fentanyl Generic | 182 | 186 | 21 | $34K |
| Famotidine Generic | 176 | 427 | 63 | $3,823 |
| Amlodipine Besylate Generic | 168 | 461 | 67 | $1,530 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 162 | 162 | 26 | $4,606 |
| Oxycontin Oxycodone Hcl | 156 | 156 | 16 | $274K |
| Trazodone Hcl Generic | 156 | 306 | 50 | $1,556 |
| Lisinopril Generic | 149 | 424 | 58 | $1,528 |
| Methadone Hcl Generic | 128 | 128 | 17 | $6,192 |
| Pregabalin Generic | 125 | 227 | 36 | $5,244 |
Brand drugs: 1,302 claims; generic drugs: 7,253 claims; opioid claims: 2,118.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel J Glatt $2,753 ($2,753 in general payments such as food, travel and fees) from 23 companies. The largest payer was Indivior Inc. with $1,156.
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. INDV | 6 | $1,156 |
| Abbvie Inc. ABBV | 7 | $159 |
| Lilly USA, LLC LLY | 7 | $154 |
| Pfizer Inc. PFE | 7 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $104 |
| Novo Nordisk Inc NVO | 4 | $97.43 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $95.14 |
| Tonix Medicines, Inc. | 1 | $84.05 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $83.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.